Jim Simons Adamis Pharmaceuticals Corp Transaction History

Renaissance Technologies LLC

  • $56.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$0.66 - $1.23 $542,952 - $1.01 Million
-822,655 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$0.54 - $1.79 $444,233 - $1.47 Million
822,655 New
822,655 $773,000
Q3 2020

Nov 13, 2020
SELL
$0.52 - $1.45 $8,896 - $24,808
-17,109 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$0.33 - $0.66 $5,645 - $11,291
17,109 New
17,109 $9,000

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email